Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)

Recently, the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) published guidelines on the management of inpatients with COVID-19. The guidelines do not recommend the use of monoclonal antibodies (mAbs) in inpatients, pending results from clinical trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Manciulli, Tommaso, Spinicci, Michele, Bartoloni, Alessandro, Zammarchi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663999/
https://www.ncbi.nlm.nih.gov/pubmed/34893959
http://dx.doi.org/10.1007/s40121-021-00565-w
_version_ 1784613763131899904
author Manciulli, Tommaso
Spinicci, Michele
Bartoloni, Alessandro
Zammarchi, Lorenzo
author_facet Manciulli, Tommaso
Spinicci, Michele
Bartoloni, Alessandro
Zammarchi, Lorenzo
author_sort Manciulli, Tommaso
collection PubMed
description Recently, the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) published guidelines on the management of inpatients with COVID-19. The guidelines do not recommend the use of monoclonal antibodies (mAbs) in inpatients, pending results from clinical trials. However, recently the Italian Drug Agency (AIFA) has allowed for the use of casirivimab/imdevimab at higher doses in hospitalized seronegative patients with COVID-19. Furthermore, several other therapeutic options based on mAbs are about to become available for outpatients. Here we provide a brief summary of the future possibilities and summarize existing data.
format Online
Article
Text
id pubmed-8663999
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-86639992021-12-10 Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) Manciulli, Tommaso Spinicci, Michele Bartoloni, Alessandro Zammarchi, Lorenzo Infect Dis Ther Letter Recently, the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) published guidelines on the management of inpatients with COVID-19. The guidelines do not recommend the use of monoclonal antibodies (mAbs) in inpatients, pending results from clinical trials. However, recently the Italian Drug Agency (AIFA) has allowed for the use of casirivimab/imdevimab at higher doses in hospitalized seronegative patients with COVID-19. Furthermore, several other therapeutic options based on mAbs are about to become available for outpatients. Here we provide a brief summary of the future possibilities and summarize existing data. Springer Healthcare 2021-12-10 2022-02 /pmc/articles/PMC8663999/ /pubmed/34893959 http://dx.doi.org/10.1007/s40121-021-00565-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Letter
Manciulli, Tommaso
Spinicci, Michele
Bartoloni, Alessandro
Zammarchi, Lorenzo
Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
title Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
title_full Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
title_fullStr Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
title_full_unstemmed Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
title_short Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP)
title_sort letter to the editor regarding management of adult patients with covid-19 outside intensive care units: guidelines from the italian society of anti-infective therapy (sita) and the italian society of pulmonology (sip)
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663999/
https://www.ncbi.nlm.nih.gov/pubmed/34893959
http://dx.doi.org/10.1007/s40121-021-00565-w
work_keys_str_mv AT manciullitommaso lettertotheeditorregardingmanagementofadultpatientswithcovid19outsideintensivecareunitsguidelinesfromtheitaliansocietyofantiinfectivetherapysitaandtheitaliansocietyofpulmonologysip
AT spiniccimichele lettertotheeditorregardingmanagementofadultpatientswithcovid19outsideintensivecareunitsguidelinesfromtheitaliansocietyofantiinfectivetherapysitaandtheitaliansocietyofpulmonologysip
AT bartolonialessandro lettertotheeditorregardingmanagementofadultpatientswithcovid19outsideintensivecareunitsguidelinesfromtheitaliansocietyofantiinfectivetherapysitaandtheitaliansocietyofpulmonologysip
AT zammarchilorenzo lettertotheeditorregardingmanagementofadultpatientswithcovid19outsideintensivecareunitsguidelinesfromtheitaliansocietyofantiinfectivetherapysitaandtheitaliansocietyofpulmonologysip

Ejemplares similares